Indraprastha Medical Corporation Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Indraprastha Medical Corporation Limited generated cash of $2,001,500,000, which is more than the previous year. Cash used in financing activities reached the amount of -$323,800,000 last year. Net change in cash is therefore $93,400,000.
Cash Flow
| 2010 | 730.06M | -360.63M | -356.79M |
|---|---|---|---|
| 2011 | 363.66M | -572.46M | 218.57M |
| 2012 | 554.69M | -279.60M | -268.31M |
| 2016 | 619.73M | -325.12M | -300.31M |
| 2018 | 477.00M | -299.02M | -172.19M |
| 2020 | 864.51M | -401.93M | -427.44M |
| 2021 | 278.98M | -201.62M | -31.47M |
| 2023 | 1.44B | -1.07B | -260.4M |
| 2024 | 2.00B | -1.58B | -323.8M |
INDRAMEDCO.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 522.6M | 417.4M | 203.32M | 168.18M | 19.37M | 19.32M | 8.03M | 43.84M | 31.20M |
Operating activities | |||||||||
Net income | 1.23B | 1.17B | 42.89M | 481.92M | 340.05M | 444.90M | 269.96M | 307.24M | 310.60M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 400.8M | 392.7M | 333.23M | 329.69M | 306.81M | 265.73M | 218.27M | 216.02M | 192.90M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 138.7M | -234.9M | 85.3M | 27.57M | 243.5M | -172.91M | 0 | 0 | 0 |
Inventories | 9.2M | 15.4M | 33.27M | -37.53M | 8.24M | -3.14M | -5.98M | -1.28M | -5.13M |
Accounts payable | 406.7M | 286.1M | -141.23M | 164.97M | -318.14M | 246.71M | 0 | 0 | 0 |
Cash generated by operating activities | 2.00B | 1.44B | 278.98M | 864.51M | 477.00M | 619.73M | 554.69M | 363.66M | 730.06M |
Investing activities | |||||||||
Purchases Of Investments | 0 | -722.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -693.9M | -445.8M | -209.63M | -409.18M | -306.92M | -327.62M | -282.11M | -573.92M | -362.73M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -1.58B | -1.07B | -201.62M | -401.93M | -299.02M | -325.12M | -279.60M | -572.46M | -360.63M |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -275.4M | -228.4M | -2.4M | -178.63M | -198.20M | -197.88M | -169.50M | -170.38M | -159.53M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -28.3M | -20.9M | -228.49M | 45M | -182.21M | -273.24M | -265.59M | -169.31M |
Cash used in financing activities | -323.8M | -260.4M | -31.47M | -427.44M | -172.19M | -300.31M | -268.31M | 218.57M | -356.79M |
Net Change In Cash | 93.4M | 105.2M | 45.89M | 35.14M | 5.78M | -5.71M | 6.77M | 9.77M | 12.63M |
Cash at end of period | 616M | 522.6M | 249.21M | 203.32M | 25.15M | 13.61M | 14.81M | 53.61M | 43.84M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |